{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:26:18Z","timestamp":1792106778918,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Sepsis is a life-threatening systemic inflammatory response triggered by infection. The rapid progression of the disease necessitates early diagnosis and precise intervention, making the identification of reliable biomarkers and therapeutic targets crucial for improving clinical outcomes and reducing sepsis-related mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>Exploring miR-142-5p as a novel diagnostic biomarker for sepsis and its therapeutic potential via targeting <jats:italic>CXCL8<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The expression levels of inflammatory factors (IL-6, TNF-\u03b1, IL-1\u03b2) and miR-142-5p in the serum of patients with sepsis and healthy controls were detected by ELISA and qPCR methods respectively. The diagnostic potential of miR-142-5p was evaluated using Pearson correlation, ROC curve, and logistic regression analyses. Bioinformatic prediction and dual-luciferase assays identified <jats:italic>CXCL8<\/jats:italic> as a target, while LPS-induced models and cell transfection experiments investigated miR-142-5p\u2019s therapeutic effects through <jats:italic>CXCL8<\/jats:italic> regulation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Sepsis patients exhibited significantly decreased miR-142-5p expression, inversely correlating with inflammatory markers (IL-6, TNF-\u03b1, IL-1\u03b2). ROC analysis showed excellent diagnostic value (AUC\u2009=\u20090.917). Pearson correlations indicated significant clinical associations, while logistic regression identified miR-142-5p as an independent protective factor (HR\u2009=\u20090.498, 95% CI:0.282\u20130.882, <jats:italic>P<\/jats:italic>\u2009=\u20090.017). LPS models confirmed miR-142-5p\u2019s anti-inflammatory effects through cytokine suppression, with knockdown showing opposite effects. Mechanistically, dual-luciferase and transfection assays verified <jats:italic>CXCL8<\/jats:italic> as a direct target mediating these effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>miR-142-5p may alleviate sepsis by targeting <jats:italic>CXCL8<\/jats:italic>-mediated inflammation, suggesting its potential as a diagnostic biomarker and therapeutic target.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00567-5","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:36:20Z","timestamp":1760013380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Regulatory effect of miR-142-5p on inflammatory process of sepsis by targeting CXCL8"],"prefix":"10.1186","volume":"162","author":[{"given":"Ling","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youfu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongcai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"567_CR1","doi-asserted-by":"crossref","unstructured":"Zampieri FG, Bagshaw SM, Semler MWJJ. Fluid therapy for critically ill adults with sepsis: a review. Jama. 2023;329(22):1967\u20131980.","DOI":"10.1001\/jama.2023.7560"},{"key":"567_CR2","doi-asserted-by":"crossref","unstructured":"Xie W, Li H, Yu T, Zhu Y, Gao J, Yang X et al. Design and synthesis of Hederagenin derivatives for the treatment of sepsis by targeting TAK1 and regulating the TAK1-NF-\u03baB\/MAPK signaling. Journal of Medicinal Chemistry. 2025. 68(3): 2694-2719.","DOI":"10.1021\/acs.jmedchem.4c02032"},{"key":"567_CR3","unstructured":"Lee K, Cascella M, Marwaha RSJID. StatPearls Publishing; Treasure Island, FL, USA: 2022."},{"key":"567_CR4","doi-asserted-by":"crossref","unstructured":"Iba T, Helms J, Connors JM, Levy JHJJoIC. The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation. Journal of Intensive Care. 2023;11(1):24.","DOI":"10.1186\/s40560-023-00672-5"},{"issue":"3","key":"567_CR5","first-page":"259","volume":"193","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Curr Estimates Limitations. 2016;193(3):259\u2013272.","journal-title":"Curr Estimates Limitations"},{"key":"567_CR6","doi-asserted-by":"crossref","unstructured":"Peltan ID, Brown SM, Bledsoe JR, Sorensen J, Samore MH, Allen TL, et al. editors. door-to-antibiotic time and long-term mortality in sepsis. Chest. 2019;155(5):938\u2013946.","DOI":"10.1016\/j.chest.2019.02.008"},{"key":"567_CR7","doi-asserted-by":"crossref","unstructured":"Ou L, Liu H-r, Shi X-y, Peng C, Zou Y-j, Jia J-w et al. Terminalia chebula retz. Aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway. Journal of ethnopharmacology. 2024;320:117428.","DOI":"10.1016\/j.jep.2023.117428"},{"key":"567_CR8","doi-asserted-by":"crossref","unstructured":"Ou L, Zhu Z, Hao Y, Li Q, Liu H, Chen Q et al. 1, 3, 6-Trigalloylglucose: a novel potent anti-Helicobacter pylori adhesion agent derived from aqueous extracts of terminalia chebula Retz. Molecules. 2024;29(5):1161.","DOI":"10.3390\/molecules29051161"},{"key":"567_CR9","doi-asserted-by":"crossref","unstructured":"Ou L, Chen H, Hao Y, Liu H, Zhu Z, Li Q et al. In vitro antibacterial activity of neochebulinic acid from aqueous extract of terminalia chebula Retz against Helicobacter pylori. BMC Complementary Medicine and Therapies. 2025;25(1):287.","DOI":"10.1186\/s12906-025-04989-6"},{"key":"567_CR10","doi-asserted-by":"crossref","unstructured":"Ambros VJC. MicroRNAs: tiny regulators with great potential. Cell. 2001;107(7):823\u2013826.","DOI":"10.1016\/S0092-8674(01)00616-X"},{"key":"567_CR11","doi-asserted-by":"crossref","unstructured":"Ambros V, Lee RC, Lavanway A, Williams PT, Jewell DJCB. MicroRNAs and other tiny endogenous RNAs in C. elegans. Current Biology. 2003;13(10):807\u2013818.","DOI":"10.1016\/S0960-9822(03)00287-2"},{"key":"567_CR12","doi-asserted-by":"crossref","unstructured":"Lu Z, Na L, Xinrui S, Jiachen Z, Min G, Yankai W et al. Enhanced therapeutic effect of IL-10-ADSCs on rabbit autoimmune dacryoadenitis by suppressing T follicular helper cell responses via miR-142-5p\/RC3H1 axis. Investigative Ophthalmology & Visual Science. 2025;66(4):66 .","DOI":"10.1167\/iovs.66.4.66"},{"key":"567_CR13","doi-asserted-by":"crossref","unstructured":"Qin-Min G, Chun-Mei H, Xiang-Yang Z, Fan B, Shu-Ming PJPO. Differentially expressed MiRNAs in sepsis-induced acute kidney injury target oxidative stress and mitochondrial dysfunction pathways. PloS one. 2017;12(3): e0173292.","DOI":"10.1371\/journal.pone.0173292"},{"key":"567_CR14","doi-asserted-by":"crossref","unstructured":"Li C, Chao Y, Guangshu C, Jiaxin L, Zhefan X, Tingting X et al. The inflammatory response induced by RELM\u03b2 upregulates IL-8 and IL-1\u03b2 expression in bronchial epithelial cells in COPD. International Journal of Chronic Obstructive Pulmonary Disease. 2021;16(0) 2503-2513.","DOI":"10.2147\/COPD.S321877"},{"key":"567_CR15","doi-asserted-by":"crossref","unstructured":"Mao Y, Zhang A, Yang H, Zhang CJC. Identification of IL-8 in CSF as a potential biomarker in sepsis-associated encephalopathy. Cytokine. 2023; 172:156390.","DOI":"10.1016\/j.cyto.2023.156390"},{"key":"567_CR16","doi-asserted-by":"crossref","unstructured":"Yunfeng Z, Wenda X, Hong ZJBR. CXCL8(3\u201372) K11R\/G31P protects against sepsis-induced acute kidney injury via NF-\u03baB and JAK2\/STAT3 pathway. Biological research. 2019;52.","DOI":"10.1186\/s40659-019-0236-5"},{"key":"567_CR17","doi-asserted-by":"crossref","unstructured":"Liu H, Karsidag M, Chhatwal K, Wang P, Tang TJPO. Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers. PLoS One. 2025;20(1):e0314745.","DOI":"10.1371\/journal.pone.0314745"},{"key":"567_CR18","doi-asserted-by":"crossref","unstructured":"Rasteh AM, Liu H, Wang PJCB. Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases. Cancer Biomarkers. 2024;41(3-4):CBM-240119.","DOI":"10.1101\/2024.11.15.623822"},{"issue":"8","key":"567_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama. 2016;315(8):801\u2013810.","journal-title":"JAMA"},{"key":"567_CR20","doi-asserted-by":"crossref","unstructured":"Huang J, Sun Z, Yan W, Zhu Y, Lin Y, Chen J et al. Identification of MicroRNA as sepsis biomarker based on MiRNAs regulatory network analysis. BioMed research internationa. 2014;2014(1):594350.","DOI":"10.1155\/2014\/594350"},{"key":"567_CR21","doi-asserted-by":"crossref","unstructured":"Kingsley SMK, Bhat BVJIR. Role of MicroRNAs in sepsis. Inflammation Research. 2017;66(7):553\u2013569.","DOI":"10.1007\/s00011-017-1031-9"},{"key":"567_CR22","doi-asserted-by":"crossref","unstructured":"Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PloS one. 2009;4(10):e7405.","DOI":"10.1371\/journal.pone.0007405"},{"key":"567_CR23","doi-asserted-by":"crossref","unstructured":"Liang G, Wu Y, Guan Y, Dong Y, Jiang L, Mao G et al. The correlations between the serum expression of miR-206 and the severity and prognosis of sepsis. Annals of palliative medicine. 2020;9(5):3222234\u201332223234.","DOI":"10.21037\/apm-20-1391"},{"key":"567_CR24","doi-asserted-by":"crossref","unstructured":"Trung NT, Lien TT, Sang VV, Hoan NX, Manh ND, Thau NS et al. Circulating miR-147b as a diagnostic marker for patients with bacterial sepsis and septic shock. PloS one. 2021;16(12):e0261228.","DOI":"10.1371\/journal.pone.0261228"},{"key":"567_CR25","doi-asserted-by":"crossref","unstructured":"Li C, Sun X, Yang X, Zhang R, Chen J, Wang XJSR. MiRNA sequencing identifies immune-associated MiRNAs and highlights the role of miR-193b-5p in sepsis and septic shock progression. Scientific Reports. 2025;15(1):5323.","DOI":"10.1038\/s41598-025-89946-6"},{"key":"567_CR26","doi-asserted-by":"crossref","unstructured":"Han R, Li W, Tian H, Zhao Y, Zhang H, Pan W et al. Urinary MicroRNAs in sepsis function as a novel prognostic marker. Experimental and Therapeutic Medicine. 2023;26(1):346.","DOI":"10.3892\/etm.2023.12045"},{"key":"567_CR27","doi-asserted-by":"crossref","unstructured":"Wenliang Z, Xiaopei H, Shi Q, Lingxiao F, Yue W, Huanzhang SJJII. miR-142-5p encapsulated by Serum-Derived extracellular vesicles protects against acute lung injury in septic rats following remote ischemic preconditioning via the PTEN\/PI3K\/Akt axis. Journal of Innate Immunity. 2022;14(5):523-542.","DOI":"10.1159\/000522231"},{"key":"567_CR28","doi-asserted-by":"crossref","unstructured":"Baghel K, Srivastava RN, Chandra A, Goel SK, Agrawal J, Kazmi HR et al. TNF-\u03b1, IL-6, and IL-8 cytokines and their association with TNF-\u03b1-308 G\/A polymorphism and postoperative sepsis. Journal of Gastrointestinal Surgery. 2014;18(8):1486\u20131494.","DOI":"10.1007\/s11605-014-2574-5"},{"key":"567_CR29","doi-asserted-by":"crossref","unstructured":"Deng P, Tang N, Li L, Zou G, Xu Y, Liu ZJMC. Diagnostic value of combined detection of IL-1\u03b2, IL-6, and TNF-\u03b1 for sepsis-induced cardiomyopathy. Medicina Cl\u00ednica. 2022;158(9):413\u2013417.","DOI":"10.1016\/j.medcli.2021.04.025"},{"key":"567_CR30","doi-asserted-by":"crossref","unstructured":"Kurt ANC, Aygun AD, Godekmerdan A, Kurt A, Dogan Y, Yilmaz EJMoi. Serum IL-1\u03b2, IL\u20106, IL\u20108, and TNF\u2010\u03b1 levels in early diagnosis and management of neonatal sepsis. Mediators of inflammation. 2007;2007(1):031397.","DOI":"10.1155\/2007\/31397"},{"key":"567_CR31","doi-asserted-by":"crossref","unstructured":"Viallon A, Zeni F, Pouzet V, Lambert C, Quenet S, Aubert G et al. Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensive care medicine. 2000;26(8):1082\u20131088.","DOI":"10.1007\/s001340051321"},{"key":"567_CR32","doi-asserted-by":"crossref","unstructured":"Zhang M, Zhao Y, Liu QJA. Tumor necrosis factor-\u03b1 \u2013\u2009308G\/A and \u2013\u2009238G\/A polymorphisms are associated with increased risks of sepsis: evidence from an updated meta\u2010analysis. Apmis. 2017;125(5):459\u2013467.","DOI":"10.1111\/apm.12661"},{"key":"567_CR33","doi-asserted-by":"crossref","unstructured":"Sean PC, Conor JK, Danielle MC, Seamus JMJCR. Diverse activators of the NLRP3 inflammasome promote IL-1\u03b2 secretion by triggering necrosis. Cell reports. 2015;11(10):1535-1548.","DOI":"10.1016\/j.celrep.2015.05.003"},{"issue":"6","key":"567_CR34","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","volume":"39","author":"C Garlanda","year":"2013","unstructured":"Garlanda C, Dinarello C, Mantovani A. The Interleukin-1 family: back to the future. Immunity. 2013;39(6):1003\u20131018.","journal-title":"Immun"},{"key":"567_CR35","doi-asserted-by":"crossref","unstructured":"Hang C-H, Shi J-X, Li J-S, Li W-Q, Wu WJJSR. Expressions of intestinal NF-\u03baB, TNF-\u03b1, and IL-6 following traumatic brain injury in rats. Journal of Surgical Research. 2005;123(2):188\u2013193.","DOI":"10.1016\/j.jss.2004.08.002"},{"key":"567_CR36","doi-asserted-by":"crossref","unstructured":"Mao L, Kitani A, Strober W, Fuss, IJJFii. The role of NLRP3 and IL-1\u03b2 in the pathogenesis of inflammatory bowel disease. Frontiers in immunology. 2018; 9:2566.","DOI":"10.3389\/fimmu.2018.02566"},{"key":"567_CR37","doi-asserted-by":"crossref","unstructured":"Shao Q, Yang HJR. Severe deformity in long-term Kaschin\u2013Beck disease. Rheumatology. 2022;61(4):1732-1732.","DOI":"10.1093\/rheumatology\/keab486"},{"key":"567_CR38","doi-asserted-by":"crossref","unstructured":"Cai D, Hu Z, Zhu Y, Ma X, Wang C, Wang C et al. CXCL8 and GZMB genes promote cartilaginous and synovial lesion formation via NF-\u03baB and MAPK signaling pathways in Kaschin\u2013Beck disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2025; 167921.","DOI":"10.1016\/j.bbadis.2025.167921"},{"key":"567_CR39","doi-asserted-by":"crossref","unstructured":"Stephen PJM, Shelley FS, Claire LN, Pauline E, vE, Daniel MF, Glenn A et al. Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis\/septic shock in the emergency department. PLoS One. 2014;9(10): e110678.","DOI":"10.1371\/journal.pone.0110678"},{"key":"567_CR40","doi-asserted-by":"crossref","unstructured":"Liu HJTGoMS. A clinical mini-review: clinical use of local anesthetics in cancer surgeries. The Gazette of Medical Sciences. 2020;1(3):030\u2013034.","DOI":"10.46766\/thegms.pharmaco.20072104"},{"key":"567_CR41","doi-asserted-by":"crossref","unstructured":"Liu HJBJoS Research T. A prospective for the potential effect of local anesthetics on stem-like cells in colon cancer. Biomedical Journal of Scientific & Technical Research. 2020;25(2):18927\u201318930.","DOI":"10.26717\/BJSTR.2020.25.004166"},{"key":"567_CR42","unstructured":"Liu HJGJCT. Nav channels in cancers: nonclassical roles. Global Journal of Cancer Therapy. 2020;6(1):5."},{"key":"567_CR43","doi-asserted-by":"crossref","unstructured":"Dong A, Rasteh AM, Liu HJB. Pan-cancer genetic analysis of mitochondrial DNA repair gene set. BioRxiv. 2024; 2024.09. 14.613048.","DOI":"10.1101\/2024.09.14.613048"},{"key":"567_CR44","doi-asserted-by":"crossref","unstructured":"Ou L, Liu H, Peng C, Zou Y, Jia J, Li H et al. Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer. Heliyon. 2024;10(17)e37046.","DOI":"10.1016\/j.heliyon.2024.e37046"},{"key":"567_CR45","doi-asserted-by":"crossref","unstructured":"Liu H, Wang PJC, Medicine E. CRISPR screening and cell line IC50 data reveal novel key genes for Trametinib resistance. Clinical and Experimental Medicine. 2024;25(1):21.","DOI":"10.1007\/s10238-024-01538-2"},{"key":"567_CR46","doi-asserted-by":"crossref","unstructured":"Liu HJWJT. Role of traditional Chinese medicine in supporting liver transplantation outcomes. World Journal of Transplantation. 2025;15(3):103904.","DOI":"10.5500\/wjt.v15.i3.103904"},{"key":"567_CR47","doi-asserted-by":"crossref","unstructured":"Liu H, Gu R-J, Li C, Wang J-X, Dong C-SJWJG. Potential of traditional Chinese medicine in managing and preventing Helicobacter pylori infection in Chinese military. World Journal of Gastroenterology. 2025;31(18):103754.","DOI":"10.3748\/wjg.v31.i18.103754"},{"key":"567_CR48","doi-asserted-by":"crossref","unstructured":"Liu HJAjocr. Pan-cancer profiles of the Cuproptosis gene set. American journal of cancer research. 2022;12(8):4074.","DOI":"10.3389\/fonc.2022.952290"},{"key":"567_CR49","doi-asserted-by":"crossref","unstructured":"Liu H, Tang TJFio. Pan-cancer genetic analysis of Cuproptosis and copper metabolism-related gene set. Frontiers in oncology. 2022; 12:952290.","DOI":"10.3389\/fonc.2022.952290"},{"key":"567_CR50","doi-asserted-by":"crossref","unstructured":"Liu H, Tang TJCG. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genetics. 2023; 278:91\u2013103.","DOI":"10.1016\/j.cancergen.2023.10.001"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00567-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00567-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00567-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:36:54Z","timestamp":1760013414000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00567-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00567-5","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of The Third Xiangya Hospital of Central South University before the study began. The written informed consent has been obtained from the participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"205"}}